Essential amino acid supplementation in patients with severe COPD: A step towards home rehabilitation

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 77, Issue 2, 2012, Pages 67-75

  Dal Negro, R W ^a,b   Testa, A ^c   Aquilani, R ^d   Tognella, S ^a   Pasini, E ^d   Barbieri, A ^e   Boschi, Federica ^e  

^a Ospedale Orlandi   (Italy)

^b Centro Nazionale Studi di Farmacoeconomia e Farmacoepidemiologia Respiratoria   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^d IRCCS   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

COPD; Essential amino acids; Physical performance; Sarcopenia

Indexed keywords

ESSENTIAL AMINO ACID; OXYGEN; PLACEBO; SERUM ALBUMIN; ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYSTEINE; HISTIDINE; ISOLEUCINE; LACTIC ACID; LEUCINE; LONG ACTING DRUG; LYSINE; METHIONINE; MUSCARINIC RECEPTOR BLOCKING AGENT; PHENYLALANINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY FAT DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HOME REHABILITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; OXYGEN SATURATION; PHYSICAL ACTIVITY; PULMONARY REHABILITATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; ANAEROBIC METABOLISM; BODY COMPOSITION; BODY MASS; BODY WEIGHT; COGNITION; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENERGY EXPENDITURE; FAT FREE MASS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; LUNG FUNCTION; MUSCLE METABOLISM; PERCEPTION; PHYSICAL PERFORMANCE; QUESTIONNAIRE; RATING SCALE; SARCOPENIA; SENSE WEAR ARMBAND; SEX DIFFERENCE; ST. GEORGE RESPIRATORY QUESTIONNAIRE; TREATMENT DURATION; TREATMENT OUTCOME; VERY ELDERLY; WALKING;

EID: 84870984929     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Viegi G, Pedreschi M, Pistelli F, et al. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000 May; 117 (5 Suppl 2): 339S-45S. (Pubitemid 30314464)
2. Dal Negro RW, Tognella S, M, et al. Costs of chronic obstructive pulmonary disease (COPD) in Italy: the SIRIO study (social impact of respiratory integrated outcomes). Respir Med 2008; 102: 92-101. (Pubitemid 350161843)
3. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007 May; 131 (5 Suppl): 4S-42S. (Pubitemid 46744215)
4. Lacasse Y, Brosseau L, Milne S, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002; (3): CD003793.
5. Review. Update in: Cochrane Database Syst Rev. 2006; (4): CD003793.
6. Garcia-Aymerich J, Farrero E, Félez MA, Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-5. (Pubitemid 36182995)
7. Griffiths TL, Phillips CJ, Davies S, et al. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001; 56: 779-84. (Pubitemid 32917548)
8. Liu Z, Barrett EJ. Human protein metabolism: its measurement and regulation. Am J Physiol EndocrinolMetab 2002; 283: E1105-12. (Pubitemid 35340615)
9. Dal Negro RW, Aquilani R, Bertacco S, et al. Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. MonaldiArch Chest Dis 2010; 73: 25-33.
10. Baldi S, Aquilani R, Pinna GD, et al. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis 2010; 5: 29-39.
11. Aquilani R, Opasich C, Gualco A et al. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur J Heart Fail 2008; 10: 1127-35.
12. Fernstrom JD. Role of precursor availability in control of monoamine biosynthesis in brain. Physiol Rev 1983; 63: 484-546. (Pubitemid 13134308)
13. Agranoff BW, Cotman CW, Uhler MD. Learning and memory. In: Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD. (eds) Basic Neurochemistry. Philadelphia, PA: Lippincott Raven, 1998; 1028-1050.
14. Langer D, Gosselink R, Sena R, Burtin C, et al. Validation of two activity monitors in patients with COPD. Thorax 2009; 64: 641-2.
15. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139: 1435-8. (Pubitemid 19155503)
16. Vandenbergh E, Van de Woestijne KP, Gyselen A. Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis. Am Rev Respir Dis 1967; 95: 556-66.
17. Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. EurRespir J 2002; 19: 626-31. (Pubitemid 34285158)
18. Baarends EM, Schols AM, Mostert R, Wouters EF. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2807-13. (Pubitemid 28052792)
19. Aquilani R, Opasich C, Verri M, et al. Is nutritional intake adequate in chronic heart failure patients? J AmColl Cardiol 2003 1; 42: 1218-23.
20. Istituto Nazionale della Nutrizione; 1989. Tabelle di composizione degli alimenti.
21. Aquilani R, Tramarin R, Pedretti RF, et al. Despite good compliance, very low fat diet alone does not achieve recommended cholesterol goals in outpatients with coronary heart disease. Eur Heart J 1999; 20: 1020-9. (Pubitemid 29306785)
22. Campbell WW, Trappe TA, Wolfe RR, Evans WJ. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. JGerontol A Biol Sci Med Sci 2001; 56: M373-80.
23. Spijkerman D C, Snijders C J, Stijnen T, Lankhorst G J. Standardization of grip strength measurements. Effects on repeatability and peak force. Scand J Rehabil Med1991; 23: 203-6.
24. Bergmeyer HU, Passoneau JV, Lowry OH. Lactate. In: Bergmeyer H.U., editor. Methods of enzymatic analysis. 2nd ed. New York: Academic Press; 1988. p. 1446-1450.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
26. Hickson M, Frost G. An investigation into the relationships between quality of life, nutritional status and physical function. Clin Nutr 2004; 23: 213-21. (Pubitemid 38401216)
27. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest2006; 129: 536-44.
28. Engelen MP, Schols AM, Baken WC, Wesseling GJ, etal. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J 1994; 7: 1793-7. (Pubitemid 24337350)
29. Schols AM, Buurman WA, Staal van den Brekel AJ, etal. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 819-24. (Pubitemid 26274084)
30. Pitsiou G, Kyriazis G, Hatzizisi O, et al. Tumor necrosis factor-alpha serum levels, weight loss and tissue oxygenation in chronic obstructive pulmonary disease. Respir Med 2002; 96: 594-8.
31. Scognamiglio R, Testa A, Aquilani R, et al. Impairment in walking capacity and myocardial function in the elderly: is there a role for non pharmacologic therapy with nutritional amino acid supplements? Am J Cardiol2008; 101 (11A): 78E-81E.
32. Kimball SR, Fabian JR, Pavitt GD, et al. Regulation of guanine nucleotide exchange through phosphorylation of eukaryotic initiation factor eIF2alpha. Role of the alpha- and delta-subunits of eiF2b. J Biol Chem 1998; 273: 12841-5. (Pubitemid 28246840)
33. Wang X, Campbell LE, Miller CM, Proud CG. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J 1998; 334: 261-7. (Pubitemid 28420997)
34. Jousse C, Bruhat A, Ferrara M, Fafournoux P. Physiological concentration of amino acids regulates insulin like-growth-factor-binding protein 1 expression. BiochemJ 1998; 334 (Pt 1): 147-53. (Pubitemid 28420983)
35. Dillon EL, Sheffield-Moore M, Paddon-Jones D, et al.Amino acid supplementation increases lean body mass, basal muscle protein synthesis, and insulin-like growth factor-I expression in older women. J Clin EndocrinolMetab 2009; 94: 1630-7.
36. Volpi E, Ferrando AA, Yeckel CW, et al. Exogenous amino acids stimulate net muscle protein synthesis in the elderly. J Clin Invest 1998; 101: 2000-7. (Pubitemid 28226120)
37. Creutzberg EC, Casaburi R. Endocrinological disturbances in chronic obstructive pulmonary disease. EurRespir J Suppl 2003; 46: 76s-80s. (Pubitemid 37351739)
38. Creutzberg EC, Wouters EF, Mostert R, et al. Efficacy of nutritional supplementation therapy in depleted patients with chronic obstructive pulmonary disease. Nutrition2003; 19: 120-7. (Pubitemid 36196765)
39. Weisberg J, Wanger J, Olson J, et al. Megestrol acetate stimulates weight gain and ventilation in underweight COPD patients. Chest 2002; 121: 1070-8. (Pubitemid 34280424)
40. Vary TC, O'Neill P, Cooney RN, et al. Chronic infusion of interleukin 1 induces hyperlactatemia and altered regulation of lactate metabolism in skeletal muscle. J Parenter Enteral Nutr 1999; 23: 213-7. (Pubitemid 29309751)
41. Xia Y, Warshaw JB, Haddad GG. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult rats. Am J Physiol 1997; 273 (5 Pt 2): R1734-41. (Pubitemid 27518126)
42. Pastoris O, Dossena M, Foppa P, et al. Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism. Neurochem Res 1995; 20: 143-50.
43. Terjung RL, Dudley GA, Meyer RA. Metabolic and circulatory limitations to muscular performance at the organ level. J Exp Biol 1985; 115: 307-18. (Pubitemid 15068834)
44. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. NEngl J Med 1996; 335: 1897-905. (Pubitemid 26419198)
45. Lehninger AL, Nelson DL, Cox MM. In: Zanichelli, editor. Principi di Biochimica 2nd ed.: 1994.
46. Brajković L, Godan A, Godan L. Quality of life after stroke in old age: comparison of persons living in nursing home and those living in their own home. CroatMed J 2009; 50: 182-8.
47. Tidermark J, Zethraeus N, Svensson O, et al. Femoral neck fractures in the elderly: functional outcome and quality of life according to euroqol. Qual Life Res 2002; 11: 473-481. (Pubitemid 34666526)
48. Mackenzie AE, Chang AM. Predictors of quality of life following stroke. Disabil Rehabil 2002; 24: 259-265. (Pubitemid 34428800)
49. Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 134-7.
50. Isoaho R, Puolijoki H, Huhti E, et al. Chronic obstructive pulmonary disease and cognitive impairment in the elderly. Int Psychogeriatr 1996; 8: 113-25. (Pubitemid 26248777)
51. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006; 20: 99-106.
52. Incalzi RA, Gemma A, Marra C, et al. Chronic obstructive pulmonary disease. An original model of cognitive decline. Am Rev Respir Dis 1993; 148: 418-24. (Pubitemid 23221588)
53. Gutteling JJ, Darlington AS, Janssen HL, et al. Effectiveness of health-related quality-of-life measurement in clinical practice: a prospective, randomized controlled trial in patients with chronic liver disease and their physicians. Qual Life Res 2008; 17: 195-205.